| 证券代码：301235 | 证券简称：华康洁净 | 公告编号：2026-014 | | --- | --- | --- | | 转债代码：123251 | 转债简称：华医转债 | | 武汉华康世纪洁净科技股份有限公司 2026 年第一次临时股东会决议公告 （一）会议召开情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、 召开时间：2026 年 2 月 5 日（星期四）14:30 特别提示 2、 召开地点：湖北省武汉市东湖新技术开发区高新大道 718 号 3 栋 29 楼 公司会议室 1、 本次股东会不存在否决议案的情形。 3、 召开方式：现场结合网络 2、 本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开及出席情况 6、 本次会议的召集、召开符合《中华人民共和国公司法》《上市公司股 东会规则》《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、部 门规章、规范性文件和《武汉华康世纪洁净科技股份有限公司章程》的有关规定。 （二）会议出席情况 1、股东出席的总体情况 参加本次股东会现场会议和网络投票表决的股东及股东代理人共 76 人，代 ...

Group 1 - The core point of the article highlights the recent stock performance of Huakang Clean, which saw a decline of 5.08%, trading at 50.25 yuan per share with a total market capitalization of 5.416 billion yuan [1] - Huakang Clean, established on November 12, 2008, is located in Wuhan, Hubei Province, and specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean is as follows: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - From the perspective of Huakang Clean's top ten circulating shareholders, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has entered the top ten shareholders, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 1.2642 million yuan [2] - The China Merchants Quantitative Selected Stock A fund was established on March 15, 2016, with a latest scale of 3.692 billion yuan, achieving a year-to-date return of 5.85% and a one-year return of 46.29% [2]

Core Viewpoint - Huakang Clean (301235) reported that as of January 30, 2026, the total number of shareholders is 15,245 [1] Group 1 - The company is actively engaging with investors through an interactive platform [1] - The total number of shareholders indicates a growing interest in the company [1] - The date mentioned suggests a future projection, highlighting the company's strategic planning [1]

Core Viewpoint - The medical device sector experienced a rise of 1.42% on February 3, with Huakang Clean leading the gains, while the overall market indices also showed positive performance [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4067.74, up by 1.29% [1]. - The Shenzhen Component Index closed at 14127.1, up by 2.19% [1]. Group 2: Top Gainers in Medical Device Sector - Huakang Clean (301235) closed at 53.83, with a gain of 9.86% and a trading volume of 114,200 shares, amounting to a transaction value of 610 million yuan [1]. - Baocait (300246) closed at 13.15, up by 7.96% with a trading volume of 178,500 shares, totaling 229 million yuan [1]. - Yirui Technology (688301) closed at 119.24, increasing by 7.10% with a trading volume of 41,000 shares, resulting in a transaction value of 477 million yuan [1]. - Hualan Co. (301093) closed at 86.08, up by 6.45% with a trading volume of 60,900 shares, totaling 482 million yuan [1]. - Tianzhihang (688277) closed at 24.18, increasing by 6.10% with a trading volume of 159,300 shares, amounting to 379 million yuan [1]. Group 3: Market Outflows and Inflows - The medical device sector saw a net outflow of 253 million yuan from institutional investors and a net outflow of 112 million yuan from speculative funds, while retail investors had a net inflow of 365 million yuan [2]. - The detailed fund flow for individual stocks indicates varying levels of net inflow and outflow among different companies [3].

Core Viewpoint - Huakang Clean (301235) emphasizes its commitment to strictly adhere to information disclosure regulations and will fulfill its disclosure obligations if annual performance meets the forecast standards [1] Group 1 - The company actively engages with investors through interactive platforms [1] - The company reassures investors about its compliance with disclosure regulations [1] - The company indicates readiness to disclose annual performance results in a timely manner if necessary [1]

Core Viewpoint - Huakang Clean announced its earnings forecast for the year 2025, projecting a net profit attributable to shareholders of between 114 million to 144 million yuan, representing a growth of 70.63% to 115.54% compared to the previous year [2] Financial Performance - The expected net profit for 2025 is estimated to be between 114 million yuan and 144 million yuan [2] - This forecast indicates a significant increase in net profit, with a growth rate ranging from 70.63% to 115.54% year-on-year [2]

Core Viewpoint - Huakang Clean (301235.SZ) expects a significant increase in net profit for the fiscal year 2025, projecting a growth of 70.63% to 115.54% compared to the previous year [1] Financial Performance - The company anticipates net profit attributable to shareholders to be between 114 million to 144 million yuan, representing a year-on-year increase of 70.63% to 115.54% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 110 million to 140 million yuan, indicating a growth of 90.71% to 142.73% year-on-year [1] - The revenue is expected to increase by over 30% compared to the same period last year, driving the profit growth [1] Business Development - The company has won multiple leading projects in various segments of the electronic clean business, covering key areas such as semiconductor materials, compound semiconductor chips, new energy materials, lidar and sensors, automotive-grade electronic components, and infrared focal plane detectors [1] - These developments are aimed at injecting clean energy into industrial upgrades [1] Future Outlook - Looking ahead to 2026, the company plans to continue expanding its service areas based on a solid foundation in the medical and laboratory sectors [1] - The goal is to become an expert in "clean technology across all application fields" and steadily move towards empowering comprehensive industrial upgrades [1]

Core Viewpoint - Huakang Clean (301235.SZ) forecasts a significant increase in net profit for the fiscal year 2025, projecting a growth of 70.63% to 115.54% year-on-year, driven by substantial revenue growth exceeding 30% compared to the previous year [1] Financial Performance - The company expects net profit attributable to shareholders to be between 114 million to 144 million yuan for 2025 [1] - The projected net profit after deducting non-recurring gains and losses is estimated to be between 110 million to 140 million yuan, reflecting a year-on-year growth of 90.71% to 142.73% [1] Business Development - The growth in net profit is primarily attributed to a significant increase in revenue, with the company securing multiple leading projects in various segments of the electronic clean business [1] - Key areas of service include semiconductor materials, compound semiconductor chips, new energy materials, lidar and sensors, automotive-grade electronic components, and infrared focal plane detectors, contributing to industry upgrades [1] Future Outlook - Looking ahead to 2026, the company aims to expand its service areas while building on its solid foundation in the medical and laboratory sectors, positioning itself as an expert in clean technology across all application fields [1] - The goal is to steadily advance towards empowering comprehensive industrial upgrades [1]

Core Viewpoint - Huakang Clean (301235.SZ) has disclosed its 2025 annual performance forecast, expecting a net profit attributable to shareholders of between 114 million yuan and 144 million yuan, representing a year-on-year growth of 70.63% to 115.54% [1] Financial Performance - The company anticipates a net profit after deducting non-recurring gains and losses to be between 110 million yuan and 140 million yuan, indicating a year-on-year increase of 90.71% to 142.73% [1]

Core Viewpoint - Huakang Clean (301235.SZ) has disclosed its earnings forecast for the fiscal year 2025, projecting a significant increase in net profit attributable to shareholders, indicating strong growth potential for the company [1] Financial Performance - The company expects net profit attributable to shareholders to be between 114 million yuan and 144 million yuan, representing a year-on-year growth of 70.63% to 115.54% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 110 million yuan and 140 million yuan, reflecting a year-on-year increase of 90.71% to 142.73% [1]